The 11th International Symposium on Myelodysplastic Syndromes took place in Edinburgh, Scotland during May 18th - 21st, 2010. Go to the web-site of the 11th International Symposium on Myelodysplastic Syndromes.
The head of the scientific program committee, the local organizing committee and the symposium chair person is professor David T. Bowen from the United Kingdom. The board members of the MDS Foundation are members of the scientific program committee.
The MDS Foundation will also arrange events for patients and relatives in connection with the this symposium.
The topics of scientific abstracts for this symposium will be:
- Clinical Outcome: General
- Diagnostics (including morphology, flow cytometry, molecular)
- Epidemiology (including demographics, quality of life, co-morbidity)
- Mouse Models
- Prognostic Factors and Models
- Supportive Care including Iron Chelation Therapy
- Stem Cell Transplantation
- High-risk MDS
- Low-risk MDS
Additionally the following topics are up for discussion at the symposium:
- 5Q-Biology and the P53 Pathway
- Allogeneic Stem Cell Transplant; Whom and When?
- Bone Marrow Failure Syndromes including Inherited Syndromes
- Co-Morbidity and Quality of Life as Prognostic Indicators
- Hypomethylating Agents and Combination Therapies
- Hypoplastic MDS and PNH
- International Research Initiatives
- Molecular Dissection of Myelodysplastic / Myeloproliferative Neoplasms
- Mouse Models of Myeloid Disease and the Microenvironment
- New Diagnostic Techniques including Flow Cytometry and Genomics
- New Prognostic Markers and Scoring Systems for Outcome
- Novel Supportive Care Strategies